Related Experiment Video

Updated: Jun 17, 2025

Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

21.6K

Inhibition of complement factor C5a or C5aR for cholesterol crystal embolism-related vascular thrombosis with

Danyang Zhao1, Chao Han2, Elmina Mammadova-Bach2

  • 1Department of Medicine IV, Hospital of Ludwig-Maximilian-University, Munich, Germany.

Kidney International
|August 14, 2024
PubMed

Insights

Targeting the C5a/C5aR pathway can prevent kidney damage and organ failure caused by cholesterol crystal embolism (CCE). Blocking C5a or C5aR effectively treats established CCE, offering a potential therapeutic strategy for high-risk patients.

Area of Science:

  • Nephrology
  • Immunology
  • Vascular Biology

Background:

  • Cholesterol crystal embolism (CCE) causes immunothrombosis, tissue necrosis, and organ failure.
  • No specific treatments are currently available for CCE.
  • CCE involves complement system activation, suggesting potential therapeutic targets.

Purpose of the Study:

  • To investigate the efficacy of C5a/C5aR axis inhibitors in attenuating CCE consequences.
  • To explore C5a/C5aR blockade as a potential treatment for CCE.

Main Methods:

  • Induction of CCE in wild-type mice via cholesterol microcrystal injection into the kidney artery.
  • Assessment of immunothrombosis, glomerular filtration rate (GFR), and kidney necrosis.
  • Evaluation of genetic deficiency (C3 or C5aR) and pharmacological blockade (C5a or C5aR inhibitors) on CCE outcomes.

Main Results:

  • Cholesterol microcrystal injection triggered rapid intra-kidney immunothrombosis and subsequent kidney injury.
  • Genetic deficiency or blockade of C3 or C5aR prevented immunothrombosis and necrosis.
  • Delayed C5a blockade effectively resolved existing clots and prevented CCE-related damage.

Conclusions:

  • Selective blockade of C5a or C5aR is sufficient to mitigate the effects of established CCE.
  • C5a/C5aR inhibition presents a feasible and safe therapeutic strategy for high-risk patients with CCE.

Keywords:
acute kidney injurycrystalsinfarctnecroinflammationthrombosis

More Related Videos

Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli13:10

Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli

Published on: September 25, 2016

9.9K
Macrophage Cholesterol Depletion and Its Effect on the Phagocytosis of Cryptococcus neoformans11:07

Macrophage Cholesterol Depletion and Its Effect on the Phagocytosis of Cryptococcus neoformans

Published on: December 19, 2014

12.7K

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
654
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.0K